Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2024 Jan 1;30(1):4-13.
doi: 10.4103/sjg.sjg_214_23. Epub 2023 Nov 18.

Endohepatology: The endoscopic armamentarium in the hand of the hepatologist

Affiliations
Review

Endohepatology: The endoscopic armamentarium in the hand of the hepatologist

Ahmed Alwassief et al. Saudi J Gastroenterol. .

Abstract

Recent advances in the field of hepatology include new and effective treatments for viral hepatitis. Further effort is now being directed to other disease entities, such as non-alcoholic fatty liver disease, with an increased need for assessment of liver function and histology. In fact, with the evolving nomenclature of fat-associated liver disease and the emergence of the term "metabolic-associated fatty liver disease" (MAFLD), new diagnostic challenges have emerged as patients with histologic absence of steatosis can still be classified under the umbrella of MAFLD. Currently, there is a growing number of endoscopic procedures that are pertinent to patients with liver disease. Indeed, interventional radiologists mostly perform interventional procedures such as percutaneous and intravascular procedures, whereas endoscopists focus on screening for and treatment of esophageal and gastric varices. EUS has proven to be of value in many areas within the realm of hepatology, including liver biopsy, assessment of liver fibrosis, measurement of portal pressure, managing variceal bleeding, and EUS-guided paracentesis. In this review article, we will address the endoscopic applications that are used to manage patients with chronic liver disease.

PubMed Disclaimer

Conflict of interest statement

There are no conflicts of interest.

References

    1. Zheng KI, Eslam M, George J, Zheng M-H. When a new definition overhauls perceptions of MAFLD related cirrhosis care. Hepatobiliary Surg Nutr. 2020;9:801. - PMC - PubMed
    1. Chang KJ, Samarasena JB, Iwashita T, Nakai Y, Lee JG. Endo-hepatology: A new paradigm. Gastrointest Endosc Clin N Am. 2012;22:379–85. - PubMed
    1. Samarasena J, Chang KJ. Endo-hepatology: A new paradigm. Endosc Ultrasound. 2018;7:219–22. - PMC - PubMed
    1. Ravipati M, Katragadda S, Swaminathan PD, Molnar J, Zarling E. Pharmacotherapy plus endoscopic intervention is more effective than pharmacotherapy or endoscopy alone in the secondary prevention of esophageal variceal bleeding: A meta-analysis of randomized, controlled trials. Gastrointest Endosc. 2009;70:658–664.e5. - PubMed
    1. Khan S, Tudur Smith C, Williamson P, Sutton R. Portosystemic shunts versus endoscopic therapy for variceal rebleeding in patients with cirrhosis. Cochrane Database Syst Rev. 2006;2006 CD000553. doi:10.1002/14651858. CD000553.pub2. - PMC - PubMed

MeSH terms